Back to Search
Start Over
PCN53 - Budget Impact and Incremental Survival Benefit of Using Lenvatinib as a Treatment for Radioactive Iodine Refractory Differentiated Thyroid Cancer in Russia.
- Source :
-
Value in Health . May2016, Vol. 19 Issue 3, pA143-A143. 1p. - Publication Year :
- 2016
Details
- Language :
- English
- ISSN :
- 10983015
- Volume :
- 19
- Issue :
- 3
- Database :
- Academic Search Index
- Journal :
- Value in Health
- Publication Type :
- Academic Journal
- Accession number :
- 115550987
- Full Text :
- https://doi.org/10.1016/j.jval.2016.03.1552